These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 27751700
1. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia. Long B, Koyfman A. J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700 [Abstract] [Full Text] [Related]
2. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. Marill KA, deSouza IS, Nishijima DK, Senecal EL, Setnik GS, Stair TO, Ruskin JN, Ellinor PT. Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763 [Abstract] [Full Text] [Related]
3. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Gorgels AP, van den Dool A, Hofs A, Mulleneers R, Smeets JL, Vos MA, Wellens HJ. Am J Cardiol; 1996 Jul 01; 78(1):43-6. PubMed ID: 8712116 [Abstract] [Full Text] [Related]
4. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. deSouza IS, Martindale JL, Sinert R. Emerg Med J; 2015 Feb 01; 32(2):161-7. PubMed ID: 24042252 [Abstract] [Full Text] [Related]
5. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment? Tomlinson DR, Cherian P, Betts TR, Bashir Y. Emerg Med J; 2008 Jan 01; 25(1):15-8. PubMed ID: 18156531 [Abstract] [Full Text] [Related]
6. Acute management of ventricular arrhythmias: role of antiarrhythmic agents. Singh BN. Pharmacotherapy; 1997 Jan 01; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341 [Abstract] [Full Text] [Related]
7. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing. Naitoh N, Washizuka T, Takahashi K, Aizawa Y. Jpn Circ J; 1998 Apr 01; 62(4):267-73. PubMed ID: 9583460 [Abstract] [Full Text] [Related]
8. Amiodarone for sustained stable ventricular tachycardia in the prehospital setting. Foerster CR, Andrew E, Smith K, Bernard S. Emerg Med Australas; 2018 Oct 01; 30(5):694-698. PubMed ID: 30084131 [Abstract] [Full Text] [Related]
9. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. Finance O, Manning A, Chatelain P. J Cardiovasc Pharmacol; 1995 Oct 01; 26(4):570-6. PubMed ID: 8569217 [Abstract] [Full Text] [Related]
10. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans. Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ. Circulation; 1993 Jan 01; 87(1):118-25. PubMed ID: 8418998 [Abstract] [Full Text] [Related]
11. Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias. Caron MF, Kluger J, White CM. Ann Pharmacother; 2001 Oct 01; 35(10):1248-54. PubMed ID: 11675855 [Abstract] [Full Text] [Related]
12. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson JL. Pacing Clin Electrophysiol; 2011 Dec 01; 34(12):1600-6. PubMed ID: 21895727 [Abstract] [Full Text] [Related]
13. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. Man KC, Williamson BD, Niebauer M, Daoud E, Bakr O, Strickberger SA, Hummel JD, Kou W, Morady F. Am J Cardiol; 1994 Dec 01; 74(11):1119-23. PubMed ID: 7977070 [Abstract] [Full Text] [Related]
14. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN. Ann Emerg Med; 2006 Mar 01; 47(3):217-24. PubMed ID: 16492484 [Abstract] [Full Text] [Related]
15. [Arrhythmias during pregnancy]. Trappe HJ. Dtsch Med Wochenschr; 2008 Sep 01; 133(36):1799-804. PubMed ID: 18767007 [Abstract] [Full Text] [Related]
16. Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction. Josephson ME. Am J Cardiol; 1996 Jul 01; 78(1):82-3. PubMed ID: 8712123 [No Abstract] [Full Text] [Related]
17. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J, PROCAMIO Study Investigators. Eur Heart J; 2017 May 01; 38(17):1329-1335. PubMed ID: 27354046 [Abstract] [Full Text] [Related]
18. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes. Brady WJ, DeBehnke DJ, Laundrie D. Acad Emerg Med; 1999 Jun 01; 6(6):609-17. PubMed ID: 10386678 [Abstract] [Full Text] [Related]
20. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases. Romito G, Gemma N, Dondi F, Mazzoldi C, Fasoli S, Cipone M. J Vet Cardiol; 2024 Jun 01; 53():20-35. PubMed ID: 38608438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]